Health & Veritas Tina Loarte-Rodríguez: Understanding Inequities in Healthcare
Dec 14, 2023
Tina Loarte-Rodríguez, Associate Director of Health Equity Measures at Yale, shares her mission to uplift Latina narratives in nursing through her book, *Latinas in Nursing*. She discusses the moral injury that inspired her writing and her personal journey into nursing. The conversation explores critical health equity measures, the significance of patient trust in data collection, and the complexities of CRISPR gene therapies for sickle cell disease—including challenges in access and the real impact on marginalized communities.
AI Snips
Chapters
Books
Transcript
Episode notes
CRISPR Therapies Are Transformative Yet Complex
- CRISPR sickle-cell therapies are revolutionary but complex, requiring months-long hospital care and risky preparatory treatments.
- Access will be limited by few capable centers and intense resource needs, so broad benefit is not guaranteed.
Cost-Effectiveness Doesn’t Solve Access
- Cost-effectiveness analyses treat one-time gene therapies differently because they may avert lifetime costs from chronic disease.
- Still, high upfront prices and long hospital courses create barriers beyond pure cost-effectiveness metrics.
Book Born From Moral Injury And Search For Role Models
- Tina started the book Latinas in Nursing after feeling morally injured by 2020's pandemic and racial injustices and finding no similar inspiration for Latinas.
- She collected diverse Latina nurse stories to uplift and build community beyond nursing specialties.
